Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

METLIFE INC Director's Dealing 2017

Mar 2, 2017

29995_dirs_2017-03-02_5bd7edb9-4cec-411c-a6c7-7345f73dc664.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2017-02-28

Reporting Person: Townsend Christopher G (President, Asia)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-28 Common Stock A 6660 $52.44 Acquired 6660 Direct
2017-02-28 Common Stock D 6660 $52.44 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-28 Employee Stock Option (Right to Buy) $52.44 A 25744 Acquired 2027-02-27 Common Stock (25744) Direct
2017-02-28 Restricted Units (Cash-Payable) $ A 8582 Acquired Common Stock (8582) Direct

Footnotes

F1: Cash payout of 2014-2016 Performance Units, following determination of the performance factor for such award. Each Performance Unit is settled in cash equal to the closing price of one share of MetLife, Inc. common stock on the payout date.

F2: The options become exercisable in three equal installments on February 28, 2018, 2019, and 2020.

F3: Each Restricted Unit is the contingent right to receive cash equal to the closing price of one share of MetLife, Inc. common stock on the vesting date.

F4: The Restricted Units vest in three equal installments on the first business day in March 2018, 2019 and 2020.